Video
Author(s):
"Active surveillance is an innovation because it's truly a departure from the idea that all prostate cancers or cancer, in general, needs to be treated," says Kara L. Watts, MD.
In this installment in Urology Times®' 50th Anniversary Innovation Celebration series, Kara L. Watts, MD, discusses the emergence and increasing uptake of active surveillance as a management strategy for men with prostate cancer. Watts, a member of the Urology Times® Editorial Council, is an assistant professor of urology at Montefiore Medical Center, Bronx, New York.